急性呼吸衰竭初始通气策略随机对照试验的方法学综述
结果发现主要终点共22种,49%的试验采用呼吸事件终点(其中76%为插管),57%的试验为阳性;在校正研究质量后,临床终点、标准化ARF管理和单中心设计与阳性结果相关。
要点
- ARF通气RCT主要终点高度异质,共使用22种不同主要终点。
- 呼吸事件终点最常见(49项,76%为插管),生理/临床终点占29%,死亡终点仅占12%。
- 校正质量后,临床终点、标准化ARF管理与单中心试验与阳性结果相关。
核心结论
- 已发表ARF初始通气策略RCT的主要终点高度异质,57%为阳性,终点类型与试验设计影响阳性结果。
关键数值与推荐
- 校正Cochrane偏倚风险工具后,临床主要终点与阳性RCT相关(OR,8.40;95% CI,1.35-65.79),标准化ARF管理(OR,4.55;95% CI,1.02-22.88)和单中心试验(OR,3.85;95% CI,1.25-13.11)亦相关。
临床怎么用
- 提示未来ARF通气试验设计应明确终点类型并考虑标准化管理,临床解读RCT结果时需关注终点选择与研究中心数量。
局限性
- 检索截至2019年12月,仅纳入已发表RCT,未报告样本量合并及异质性定量指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Randomized controlled trials (RCTs) in patients with hypoxemic acute respiratory failure (ARF) often failed to show survival benefits and resulted in varying clinical end points. RESEARCH QUESTION: This methodologic review was conducted of published RCTs on ARF, with a careful attention to whether the study results were positive or negative. STUDY DESIGN AND METHODS: MEDLINE, Cochrane Central Register of Controlled Trials, and Web of Science were searched for published RCTs in adult patients with ARF between January 1995 and December 2019. The objective was to investigate sources of heterogeneity and factors associated with a positive RCT (ie, with a significant difference on the primary end point). To determine the importance of the primary end point choice, end points were classified as follows: (1) respiratory event end points (corresponding to modification of the ventilation support); (2) physiologic/clinical end points (corresponding to oxygenation or clinical parameters); and (3) mortality. The Cochrane risk-of-bias tool was used to assess study quality. RESULTS: Seventy-four RCTs were included (57% were single-center RCTs) comparing mainly oxygenation/ventilation strategies (95%) in patients with various ARF causes (62%); studies were stopped prematurely in 20% of the trials. A standardized management of ARF was observed in 24 (32%) trials. Twenty-two distinct primary end points have been used, the first of which were those based on respiratory events (44 RCTs [49%]), namely intubation in 76% of the cases. Physiologic/clinical end points have been used in 21 trials (29%) and mortality in nine (12%). Overall, 42 (57%) RCTs were positive, 52% in studies with respiratory event end points, 76% in studies with physiologic/clinical end points, and 33% in studies with mortality end points. Adjusted for study quality (Cochrane risk-of-bias tool), factors associated with a positive RCT included clinically based primary end points (OR, 8.40; 95% CI, 1.35-65.79), the use of standardized ARF management (OR, 4.55; 95% CI, 1.02-22.88), and single-center trials (OR, 3.85; 95% CI, 1.25-13.11). INTERPRETATION: The typology of published RCTs in patients with ARF could be used to frame future trial designs in this field and guide clinicians and researchers toward optimal research transfer to the bedside.
引用
- Dumas G, Chevret S, Le Corre M, et al. Typology of Published Randomized Controlled Trials Investigating Initial Ventilation Strategy in Critically Ill Patients With Acute Respiratory Failure: A Methodologic Review. Chest. 2020. PMID: 32387523. doi:10.1016/j.chest.2020.03.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。